View drug registration information details.
Items | Registration information |
ID | 302 |
No | 302 |
Brand Name | DIFLUVID |
Ingredients | FLUCONAZOLE 150 MG |
Dosage Form | CAPSULE |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 30"C |
Shelf Life | 3 YEARS |
Pack Size | 4 CAPSULE/BOX |
Dispensing Category | Prescription only |
ATC Classification | G01AG01 |
Pharmaceutical Class | ANTIFUNGAL |
Indications | - MUCOSAL CANDIDIASIS. THESE INCLUDE OROPHARYNGEAL, ESOPHAGEAL, NON INVASIVE BRONCHOPULMONARY INFECTIONS, CANDIDURIA,
- GENITAL CANDIDIASIS : VAGINAL CANDIDIASIS, ACUTE OR RECURRENT AND PROPHYLAXIS TO REDUCE THE INCIDENCE OF RECURRENT VAGINAL CANDIDIASIS |
Contraindications | FLUCONAZOLE SHOULD NOT BE USED IN PATIENTS WITH KNOWN SENSITIVITY TO THE DRUG, ANY OF THE INERT INGREDIENTS OR TO RELATED AZOLE COMPOUNDS. |
Side Effects | INCREASED RISK OF EXFOLIATIVE SKIN DISORDERS , INCLUDING STEVENS - JOHNSON SYNDROM, AGRANULOCYTOSIS AND THROMBOCYTOPENNIA. |
Unit Price | 1.48 |
EDL |
Yes |
Description | LIGHT TURQUOISE OPAQUE/LIGHT TURQUOISE OPAQUE CAPSULE WITH "HOVID" PRINTED ON ONE END AND "FL 150"PRINTED ON THE OTHER END OF THE CAPSULE. THE CAPSULE IS FILLED WITH WHITE TO OFF - WHITE POWDER. |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL09072798AZ |
Import Registration Date | 2014-07-31 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-03-31 |
FDD Registration No | 02 I 4211/17 |
FDD Registration Date | 2023-06-07 |
Expiry Date | 2026-06-06 |
Back to drug list
|